Mass spectrometry is a powerful analytical tool that has been widely used in the biotech industry. Recent trends of implementing a liquid chromatography-mass spectrometry (LC-MS) based multi-attribute method (MAM) in cGMP environments enables end-to-end monitoring and control of critical quality attributes (CQAs) of therapeutic proteins to ensure drug product quality.

中文翻译：

---

在cGMP环境中推进质谱技术。

质谱分析是一种功能强大的分析工具，已在生物技术行业中广泛使用。在cGMP环境中实施基于液相色谱-质谱（LC-MS）的多属性方法（MAM）的最新趋势，可以对治疗性蛋白质的关键质量属性（CQA）进行端到端监视和控制，以确保药品质量。